Temporal acquistion of enhanced fibrinolytic activity by syrian hamster embryo cells following treatment with benzo(a)pyrene. 1977

J C Barrett, and B D Crawford, and D L Grady, and L D Hester, and P A Jones, and W F Benedict, and P O Ts'o

Following treatment of Syrian hamster embryo cells with benzo(a)pyrene, the time required for the expression of enhanced fibrinolytic activity was examined. For this study, the fibrin-agarose overlay method was developed to distinguish the activity of normal and transformed colonies of hamster cells. Colonies possessing enhanced fibrinolytic activity were not observed one passage (2 weeks after treatment). Morphologically transformed colonies, which exhibited no enhanced fibrinolytic activity, were observed 8 days following treatment. In contrast to these two early changes, cells capable of growth in soft agar were observed much later (6 to 8 weeks after treatment). Untreated Syrian hamster embryo cells generally senesced and did not exhibit enhanced fibrinolytic activity. Approximately 1 of 10 untreated cultures escaped senescence and evolved as a continuous cell line; such cultures frequently exhibited enhanced fibrinolytic activity. These results suggest that the acquisition of enhanced fibrinolytic activity, while perhaps not a cause of neoplastic transformation, may reflect a loss of control of the normal function of the cellular genetic apparatus during the process of transformation.

UI MeSH Term Description Entries
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002999 Clone Cells A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed) Clones,Cell, Clone,Cells, Clone,Clone,Clone Cell
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D005337 Fibrin A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot. Antithrombin I
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D001580 Benzopyrenes A class of chemicals that contain an anthracene ring with a naphthalene ring attached to it. Benzpyrene
D012685 Sepharose Agarose,Sepharose 4B,Sepharose C1 4B,4B, Sepharose C1,C1 4B, Sepharose
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

J C Barrett, and B D Crawford, and D L Grady, and L D Hester, and P A Jones, and W F Benedict, and P O Ts'o
January 1983, Pharmacology,
J C Barrett, and B D Crawford, and D L Grady, and L D Hester, and P A Jones, and W F Benedict, and P O Ts'o
July 1978, Chemico-biological interactions,
J C Barrett, and B D Crawford, and D L Grady, and L D Hester, and P A Jones, and W F Benedict, and P O Ts'o
January 1981, Carcinogenesis,
J C Barrett, and B D Crawford, and D L Grady, and L D Hester, and P A Jones, and W F Benedict, and P O Ts'o
June 1988, Carcinogenesis,
J C Barrett, and B D Crawford, and D L Grady, and L D Hester, and P A Jones, and W F Benedict, and P O Ts'o
November 1986, Cancer letters,
J C Barrett, and B D Crawford, and D L Grady, and L D Hester, and P A Jones, and W F Benedict, and P O Ts'o
August 2001, Mutation research,
J C Barrett, and B D Crawford, and D L Grady, and L D Hester, and P A Jones, and W F Benedict, and P O Ts'o
January 1986, Environmental mutagenesis,
J C Barrett, and B D Crawford, and D L Grady, and L D Hester, and P A Jones, and W F Benedict, and P O Ts'o
December 1990, Toxicology,
J C Barrett, and B D Crawford, and D L Grady, and L D Hester, and P A Jones, and W F Benedict, and P O Ts'o
August 1971, Proceedings of the National Academy of Sciences of the United States of America,
J C Barrett, and B D Crawford, and D L Grady, and L D Hester, and P A Jones, and W F Benedict, and P O Ts'o
October 1982, Cancer research,
Copied contents to your clipboard!